News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
India’s Strides Arcolab Limited Ends Joint Venture with ACCU-BREAK Pharmaceuticals, Inc.
May 2, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, May 2 (Reuters) - India's Strides Arcolab Ltd. (STAR.BO: Quote, Profile , Research) said on Wednesday it had terminated a joint venture agreement with ACCU-BREAK Pharmaceuticals Inc., citing changes in the U.S. company's business model.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
MORE ON THIS TOPIC
Earnings
Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value
August 7, 2025
·
3 min read
·
Annalee Armstrong
Cancer
Big Pharma-Backed mRNA Startup Bags $153M Series B Amid Policy Headwinds
August 7, 2025
·
2 min read
·
Tristan Manalac
Earnings
Despite Safety Drama, Sarepta Beats Q2 Estimates—But No Thanks to Elevidys Sales
August 7, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH CRESSET
From Chat Bots to World Order: The Race for the 21st Century’s Operating System
August 7, 2025
·
1 min read
·
Lori Ellis